Train Blast in Quetta Injures Dozens Raises Security Concerns for Pakistans Transport Sector Indian Equity Markets End Week Higher Amid USIran Diplomacy Focus TrumpXi Summit Yields Soybean and Rare Earths Deals China Signals Potential Tariff Cuts Sony PlayStation Plus Price Increases Trigger Gamer Backlash Subscription Costs Under Scrutiny SP 500 Notches Modest Gains as Healthcare and Tech Lead Communication Services Lags Retail Investors Gain Unprecedented Access to SpaceX IPO via Major Brokerage Platforms HTB Q1 2026 Earnings Earnings Beat Expectations with Strong EPS Surprise of 1994 Actelis Networks Q1 2026 Earnings EPS Surprise of 80 Highlights Cost Management Amid Revenue Disclosure Gap DTIL Q1 2026 Earnings EPS Misses Estimates as Gene Editing Pipeline Progress Takes Center Stage VNO Q1 2026 Earnings EPS Misses as Office Headwinds Persist OBK Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction MSCI Q1 2026 Earnings EPS Slightly Beats Estimates Amid Steady Performance CHS Inc CHSCM Holds Steady Near Support as Price Action Remains RangeBound Live Nation Entertainment LYV Holds Steady Near Support as Market Weighs Event Demand Bitcoin Infrastructure Acquisition BIXI Shows Stability Near 999 Limited Movement but Key Levels in Focus SolGel Technologies SLGL Holds Steady Just Below Key Resistance After Modest Gain Picard Medical Inc PMI Faces Heavy Selling Pressure as Shares Slide Below Critical Support United Therapeutics UTHR Slips 152 as Biotech Sector Faces Headwinds Support and Resistance in Focus Regency Centers REG Holds Steady Near Support as Retail Real Estate Shows Resilience Thayer Ventures Acquisition TVAI Holds Steady at 1029 as SPAC Market Watches for Catalyst GoDaddy Inc GDDY Hovers Near Support as Modest Decline Reflects Cautious Trading Semtech SMTC Surges 7 Momentum Builds Above Key Support Apogee Therapeutics APGE Faces Steep Decline Testing Key Support Levels Morgan Stanley Adjusts Walmart Forecast Amid Persistent Inflation Pressures WSC Q1 2026 Earnings EPS Misses Estimates as Stock Slightly Declines DiaMedica Therapeutics DMAC Gains 243 as Buyers Defend Key Support